CHKA and osteosarcoma: The association between impaired CHKA activity and elevated lipid peroxidation is further supported by our findings in U2OS bone osteosarcoma cells and SH-SY5Y neuroblastoma cells treated with the CHKA inhibitor EB-3D, which demonstrated a dose-dependent increase in lipid peroxidation (Fig. S1).